Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-02-06
1980-11-18
Schafer, Richard E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112B, 424 8, 424 12, G01N 3316, A61K 4300
Patent
active
042345618
ABSTRACT:
Antisera suitable for detecting the presence of human chorionic gonadotropin in body fluids by immunoassay are prepared by administering to a host animal an antigen comprising the .beta.-subunit of human chorionic gonadotropin which has been modified by cleaving and optionally conjugating the thus modified .beta.-subunit with a protein or hapten capable of enhancing the immunogenetic potency of the antigen. The antigens are also useful for the contraceptive purposes to terminate pregnancy.
REFERENCES:
patent: 3903262 (1975-09-01), Pappenhagen et al.
patent: 3992514 (1976-11-01), Donini
patent: 4016250 (1977-05-01), Saxena
Bahl et al., Biochem. Biophys., Res. Comm., vol. 70, No. 2, May 17, 1976, pp. 525-532.
Tawar et al., Proc. Nat. Acad. Sci, USA, vol. 72, No. 1, Jan., 1976, pp. 218-222.
Bahl et al., Chemical Abstracts, vol. 85, No. 11, Sep. 13, 1976, p. 184, Abstract No. 73750j.
Nucker Christine M.
Research Corporation
Schafer Richard E.
LandOfFree
Antigen for early pregnancy test and contraceptive vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen for early pregnancy test and contraceptive vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen for early pregnancy test and contraceptive vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597802